Insights

CBD (cannabidiol) has risen significantly in profile in recent years. Its growing popularity among researchers, patients and casual users alike merits a discussion of its therapeutic promise. This paper provides an overview of clinical applications of CBD that are currently under investigation by the pharmaceutical industry and offers some remarks on the future prospects of CBD-based products.

In the midst of an unprecedented health emergency, it may seem strange to speak of ‘gains’, i.e. gains from our experience in combatting COVID-19. The loss of loved ones through COVID-19 is a terrible tragedy and no ‘gain’ or advances in our approach can ever outweigh this loss. But in this context, we face an even greater responsibility to be clear on what we are learning from this crisis and how we see these lessons can benefit others in the future post-COVID world.

Dr Charles Alessi speaks about COVID-19 "exit strategy" based on the use of telemedicine, secondary use of medical data and global hypercollaboration at Public Policy Projects.

Lecture by Prof. Richard Barker at Gowing Life (Oxford, UK)